Very proud to add a publication about impact of dose reduction of BCG on NMIBC. Thrilled to work with great professionals @SauUrologia @CAU_URO @Blatam_urology @sanatorioargent @IAF_Fleming @Uroweb @BladderCaJrnl https://t.co/xqQp4ibJuu https://t.
A nice study on BCG dose and oncological outcomes in @BladderCaJrnl https://t.co/jzkMdnDt8U Systemic and local toxicity are difficult to model in pre-clinical studies. Host immunocompetence, a critical aspect of response to BCG ! An older impt. read here,
RT @BladderCaJrnl: Check out NEW SYSTEMATIC REVIEW: BCG Dose Reduction for Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta…
RT @BladderCaJrnl: Check out NEW SYSTEMATIC REVIEW: BCG Dose Reduction for Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta…